Fenofibrate Nanocrystalize
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D220R0073
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
The Defense Logistics Agency (DLA) Troop Support, a federal office, has issued a solicitation for the procurement of Fenofibrate Nanocrystalize Tablets under solicitation number SPE2D220R0073. This procurement falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code 6505, indicating a focus on pharmaceuticals and related products.
The primary objective of this solicitation is to secure a reliable supply of Fenofibrate Nanocrystalize Tablets, a pharmaceutical product used in the management of cholesterol and triglyceride levels. The intended outcome is to ensure that DLA Troop Support can meet the ongoing medical and pharmaceutical needs of its stakeholders, likely including military personnel and associated beneficiaries.
The scope of the procurement includes the manufacturing and delivery of Fenofibrate Nanocrystalize Tablets in accordance with the specifications and requirements outlined in the solicitation documents. Contractors are expected to comply with all applicable federal regulations and quality standards for pharmaceutical manufacturing. The solicitation has undergone several modifications, including the incorporation of FAR Clause 52.204-27, which prohibits the use of Bytedance covered applications (as of June 2023), and the exercise of option periods to extend contract performance through April 2024. Additionally, a no-cost settlement termination for convenience has been noted, indicating the government's right to terminate the contract without penalty under certain circumstances.
The solicitation is currently active, with the original closing date extended to October 23, 2020, at 3:00 PM EDT, as per Amendment 0001. Interested contractors should review all six attachments available on the SAM.gov opportunity page for detailed requirements, terms, and conditions.
DLA Troop Support serves as the contracting entity, and all inquiries regarding this opportunity should be directed to the primary contact, Phyllis Daraio, who can be reached via email at [email protected] or by phone at 215-737-7941.
This procurement is a formal solicitation and does not specify any set-aside requirements or special considerations beyond the standard federal acquisition regulations and the noted prohibition on Bytedance applications. Contractors with capabilities in pharmaceutical preparation manufacturing, particularly those experienced in producing nanocrystalized formulations, are encouraged to evaluate the solicitation documents to determine alignment with their expertise and capacity.
For further details and to access the solicitation attachments, interested parties should refer to the official notice on SAM.gov using Opportunity ID 983dc145b41f46b3810acc6497292449.
Documents6